_version_ 1784699698580291584
author Guarino, M.
Esposito, I.
Portella, G.
Cossiga, V.
Loperto, I.
Pignata, L.
Tortora, R.
Attanasio, M.R.
Cennamo, M.
Capasso, M.
Terracciano, D.
Cutolo, F.M.
Lanza, A.G.
Lieto, R.
Di Somma, S.
Picciotto, F.P.
Morisco, F.
author_facet Guarino, M.
Esposito, I.
Portella, G.
Cossiga, V.
Loperto, I.
Pignata, L.
Tortora, R.
Attanasio, M.R.
Cennamo, M.
Capasso, M.
Terracciano, D.
Cutolo, F.M.
Lanza, A.G.
Lieto, R.
Di Somma, S.
Picciotto, F.P.
Morisco, F.
author_sort Guarino, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9065938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90659382022-05-04 OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS Guarino, M. Esposito, I. Portella, G. Cossiga, V. Loperto, I. Pignata, L. Tortora, R. Attanasio, M.R. Cennamo, M. Capasso, M. Terracciano, D. Cutolo, F.M. Lanza, A.G. Lieto, R. Di Somma, S. Picciotto, F.P. Morisco, F. Dig Liver Dis Oral Communications Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022-05 2022-05-04 /pmc/articles/PMC9065938/ http://dx.doi.org/10.1016/S1590-8658(22)00357-7 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Oral Communications
Guarino, M.
Esposito, I.
Portella, G.
Cossiga, V.
Loperto, I.
Pignata, L.
Tortora, R.
Attanasio, M.R.
Cennamo, M.
Capasso, M.
Terracciano, D.
Cutolo, F.M.
Lanza, A.G.
Lieto, R.
Di Somma, S.
Picciotto, F.P.
Morisco, F.
OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
title OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
title_full OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
title_fullStr OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
title_full_unstemmed OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
title_short OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
title_sort oc.15.2 humoral response to 2-dose bnt162b2 mrna vaccine for covid-19 in liver transplant recipients
topic Oral Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065938/
http://dx.doi.org/10.1016/S1590-8658(22)00357-7
work_keys_str_mv AT guarinom oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT espositoi oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT portellag oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT cossigav oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT lopertoi oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT pignatal oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT tortorar oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT attanasiomr oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT cennamom oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT capassom oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT terraccianod oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT cutolofm oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT lanzaag oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT lietor oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT disommas oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT picciottofp oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients
AT moriscof oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients